AFP and hepatocellular carcinoma: Similarly, more patients in the non-screened cohort had a baseline AFP ≥400 ng/mL, potentially reflecting an increased tumor burden when HCC is diagnosed outside of a screening protocol compared to diagnoses made within the context of screening protocols.